{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T13:29:41Z","timestamp":1791379781423,"version":"4.3.3"},"reference-count":109,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PS156324"],"award-info":[{"award-number":["PS156324"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PS148577"],"award-info":[{"award-number":["PS148577"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["MOP 106518"],"award-info":[{"award-number":["MOP 106518"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["MOP 69043"],"award-info":[{"award-number":["MOP 69043"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009232","name":"Agencia Nacional de Promoci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["PICT 2015-1178"],"award-info":[{"award-number":["PICT 2015-1178"]}],"id":[{"id":"10.13039\/501100009232","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.bcp.2018.07.005","type":"journal-article","created":{"date-parts":[[2018,7,11]],"date-time":"2018-07-11T02:18:56Z","timestamp":1531275536000},"page":"233-241","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"special_numbering":"C","title":["Pharmacological intervention of liver triacylglycerol lipolysis: The good, the bad and the ugly"],"prefix":"10.1016","volume":"155","author":[{"given":"Ariel D.","family":"Quiroga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Lehner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.bcp.2018.07.005_b0005","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1002\/hep.23594","article-title":"Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection","volume":"51","author":"Starley","year":"2010","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.bcp.2018.07.005_b0010","first-page":"762","article-title":"Liver triacylglycerol lipases","volume":"1821","author":"Quiroga","year":"2012","journal-title":"BBA"},{"issue":"5700","key":"10.1016\/j.bcp.2018.07.005_b0015","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1126\/science.1100747","article-title":"Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase","volume":"306","author":"Zimmermann","year":"2004","journal-title":"Science"},{"issue":"20","key":"10.1016\/j.bcp.2018.07.005_b0020","doi-asserted-by":"crossref","first-page":"17467","DOI":"10.1074\/jbc.M110.215434","article-title":"Monoglyceride lipase deficiency in mice impairs lipolysis and attenuates diet-induced insulin resistance","volume":"286","author":"Taschler","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2018.07.005_b0025","doi-asserted-by":"crossref","first-page":"26839","DOI":"10.1155\/2007\/26839","article-title":"Comprehensive analysis of PPARalpha-dependent regulation of hepatic lipid metabolism by expression profiling","volume":"2007","author":"Rakhshandehroo","year":"2007","journal-title":"PPAR Res."},{"issue":"12","key":"10.1016\/j.bcp.2018.07.005_b0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1007110","article-title":"Adipose tissue deficiency of hormone-sensitive lipase causes fatty liver in mice","volume":"13","author":"Xia","year":"2017","journal-title":"PLoS Genet."},{"issue":"Pt 11","key":"10.1016\/j.bcp.2018.07.005_b0035","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1242\/jcs.045849","article-title":"Coatomer-dependent protein delivery to lipid droplets","volume":"122","author":"Soni","year":"2009","journal-title":"J. Cell Sci."},{"issue":"5","key":"10.1016\/j.bcp.2018.07.005_b0040","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.cmet.2006.03.005","article-title":"Adipose triglyceride lipase-mediated lipolysis of cellular fat stores is activated by CGI-58 and defective in Chanarin-Dorfman syndrome","volume":"3","author":"Lass","year":"2006","journal-title":"Cell Metab."},{"issue":"10 Pt B","key":"10.1016\/j.bcp.2018.07.005_b0045","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.bbalip.2017.06.007","article-title":"G0S2: a small giant controller of lipolysis and adipose-liver fatty acid flux","volume":"1862","author":"Zhang","year":"2017","journal-title":"Biochim. Biophys. Acta"},{"issue":"3","key":"10.1016\/j.bcp.2018.07.005_b0050","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1194\/jlr.M082388","article-title":"Hypoxia-inducible lipid droplet-associated protein inhibits adipose triglyceride lipase","volume":"59","author":"Padmanabha Das","year":"2018","journal-title":"J. Lipid Res."},{"issue":"50","key":"10.1016\/j.bcp.2018.07.005_b0055","doi-asserted-by":"crossref","first-page":"34538","DOI":"10.1074\/jbc.M109.068478","article-title":"Perilipin controls lipolysis by regulating the interactions of AB-hydrolase containing 5 (Abhd5) and adipose triglyceride lipase (Atgl)","volume":"284","author":"Granneman","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"5774","key":"10.1016\/j.bcp.2018.07.005_b0060","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1126\/science.1123965","article-title":"Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase","volume":"312","author":"Haemmerle","year":"2006","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.bcp.2018.07.005_b0065","doi-asserted-by":"crossref","first-page":"E289","DOI":"10.1152\/ajpendo.00099.2009","article-title":"Neutral lipid storage disease: genetic disorders caused by mutations in adipose triglyceride lipase\/PNPLA2 or CGI-58\/ABHD5","volume":"297","author":"Schweiger","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.bcp.2018.07.005_b0070","doi-asserted-by":"crossref","DOI":"10.1002\/hep.24338","article-title":"Deficiency of liver adipose triglyceride lipase in mice causes progressive hepatic steatosis","author":"Wu","year":"2011","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.bcp.2018.07.005_b0075","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1194\/jlr.M001073","article-title":"Adipose triglyceride lipase plays a key role in the supply of the working muscle with fatty acids","volume":"51","author":"Schoiswohl","year":"2010","journal-title":"J. Lipid Res."},{"issue":"10","key":"10.1016\/j.bcp.2018.07.005_b0080","doi-asserted-by":"crossref","first-page":"3610","DOI":"10.1210\/en.2015-1322","article-title":"Impact of Reduced ATGL-Mediated Adipocyte Lipolysis on Obesity-Associated Insulin Resistance and Inflammation in Male Mice","volume":"156","author":"Schoiswohl","year":"2015","journal-title":"Endocrinology"},{"issue":"12","key":"10.1016\/j.bcp.2018.07.005_b0085","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/nchembio.1359","article-title":"Development of small-molecule inhibitors targeting adipose triglyceride lipase","volume":"9","author":"Mayer","year":"2013","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.bcp.2018.07.005_b0090","doi-asserted-by":"crossref","first-page":"14859","DOI":"10.1038\/ncomms14859","article-title":"Pharmacological inhibition of adipose triglyceride lipase corrects high-fat diet-induced insulin resistance and hepatosteatosis in mice","volume":"8","author":"Schweiger","year":"2017","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bcp.2018.07.005_b0095","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1210\/en.2010-0661","article-title":"Adipose triglyceride lipase-null mice are resistant to high-fat diet-induced insulin resistance despite reduced energy expenditure and ectopic lipid accumulation","volume":"152","author":"Hoy","year":"2011","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.bcp.2018.07.005_b0100","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1194\/jlr.D058438","article-title":"Simplified assays of lipolysis enzymes for drug discovery and specificity assessment of known inhibitors","volume":"57","author":"Iglesias","year":"2016","journal-title":"J. Lipid Res."},{"issue":"47","key":"10.1016\/j.bcp.2018.07.005_b0105","doi-asserted-by":"crossref","first-page":"32559","DOI":"10.1074\/jbc.M114.602599","article-title":"A peptide derived from G0\/G1 switch gene 2 acts as noncompetitive inhibitor of adipose triglyceride lipase","volume":"289","author":"Cerk","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.bcp.2018.07.005_b0110","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.1016\/j.bmc.2015.02.051","article-title":"Structure-activity studies in the development of a hydrazone based inhibitor of adipose-triglyceride lipase (ATGL)","volume":"23","author":"Mayer","year":"2015","journal-title":"Bioorg. Med. Chem."},{"issue":"4","key":"10.1016\/j.bcp.2018.07.005_b0115","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1074\/jbc.M113.522011","article-title":"Defective adipose lipolysis and altered global energy metabolism in mice with adipose overexpression of the lipolytic inhibitor G0\/G1 switch gene 2 (G0S2)","volume":"289","author":"Heckmann","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.bcp.2018.07.005_b0120","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1111\/cbdd.13029","article-title":"Design and synthesis of Atglistatin derivatives as adipose triglyceride lipase inhibitors","volume":"90","author":"Jin","year":"2017","journal-title":"Chem. Biol. Drug Des."},{"issue":"4","key":"10.1016\/j.bcp.2018.07.005_b0125","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/(SICI)1098-2280(1998)31:4<362::AID-EM9>3.0.CO;2-K","article-title":"S-oxygenation of thiourea results in the formation of genotoxic products","volume":"31","author":"Ziegler-Skylakakis","year":"1998","journal-title":"Environ. Mol. Mutagen."},{"issue":"19","key":"10.1016\/j.bcp.2018.07.005_b0130","doi-asserted-by":"crossref","first-page":"13087","DOI":"10.1074\/jbc.M800533200","article-title":"Hepatic overexpression of hormone-sensitive lipase and adipose triglyceride lipase promotes fatty acid oxidation, stimulates direct release of free fatty acids, and ameliorates steatosis","volume":"283","author":"Reid","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.bcp.2018.07.005_b0135","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1124\/jpet.117.243253","article-title":"Novel pharmacological probes reveal ABHD5 as a locus of lipolysis control in white and brown adipocytes","volume":"363","author":"Rondini","year":"2017","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"4","key":"10.1016\/j.bcp.2018.07.005_b0140","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1254\/jphs.13149FP","article-title":"Fibrates reduce triacylglycerol content by upregulating adipose triglyceride lipase in the liver of rats","volume":"123","author":"Karahashi","year":"2013","journal-title":"J. Pharmacol. Sci."},{"issue":"2","key":"10.1016\/j.bcp.2018.07.005_b0145","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1073\/pnas.97.2.787","article-title":"Targeted disruption of hormone-sensitive lipase results in male sterility and adipocyte hypertrophy, but not in obesity","volume":"97","author":"Osuga","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"7","key":"10.1016\/j.bcp.2018.07.005_b0150","doi-asserted-by":"crossref","first-page":"4806","DOI":"10.1074\/jbc.M110355200","article-title":"Hormone-sensitive lipase deficiency in mice causes diglyceride accumulation in adipose tissue, muscle, and testis","volume":"277","author":"Haemmerle","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.bcp.2018.07.005_b0155","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1194\/jlr.R200009-JLR200","article-title":"Hormone-sensitive lipase: control of intracellular tri-(di-)acylglycerol and cholesteryl ester hydrolysis","volume":"43","author":"Kraemer","year":"2002","journal-title":"J. Lipid Res."},{"issue":"11","key":"10.1016\/j.bcp.2018.07.005_b0160","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.2337\/diabetes.54.11.3190","article-title":"Adipocyte lipases and defect of lipolysis in human obesity","volume":"54","author":"Langin","year":"2005","journal-title":"Diabetes"},{"issue":"24","key":"10.1016\/j.bcp.2018.07.005_b0165","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1056\/NEJMoa1315496","article-title":"Null mutation in hormone-sensitive lipase gene and risk of type 2 diabetes","volume":"370","author":"Albert","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.bcp.2018.07.005_b0170","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1194\/jlr.M300190-JLR200","article-title":"Decreased fatty acid esterification compensates for the reduced lipolytic activity in hormone-sensitive lipase-deficient white adipose tissue","volume":"44","author":"Zimmermann","year":"2003","journal-title":"J. Lipid Res."},{"issue":"10","key":"10.1016\/j.bcp.2018.07.005_b0175","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.chembiol.2006.09.010","article-title":"Small-molecule compounds that modulate lipolysis in adipose tissue: targeting strategies and molecular classes","volume":"13","author":"Wang","year":"2006","journal-title":"Chem. Biol."},{"issue":"22","key":"10.1016\/j.bcp.2018.07.005_b0180","doi-asserted-by":"crossref","first-page":"5449","DOI":"10.1021\/jm0607653","article-title":"Synthesis and structure-activity relationship for a novel class of potent and selective carbamate-based inhibitors of hormone selective lipase with acute in vivo antilipolytic effects","volume":"50","author":"Ebdrup","year":"2007","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.bcp.2018.07.005_b0185","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1124\/jpet.105.086926","article-title":"Specific inhibition of hormone-sensitive lipase improves lipid profile while reducing plasma glucose","volume":"315","author":"Claus","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"5","key":"10.1016\/j.bcp.2018.07.005_b0190","doi-asserted-by":"crossref","first-page":"E1188","DOI":"10.1152\/ajpendo.00051.2007","article-title":"Role of hormone-sensitive lipase in beta-adrenergic remodeling of white adipose tissue","volume":"293","author":"Mottillo","year":"2007","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.bcp.2018.07.005_b0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1001485","article-title":"Partial inhibition of adipose tissue lipolysis improves glucose metabolism and insulin sensitivity without alteration of fat mass","volume":"11","author":"Girousse","year":"2013","journal-title":"PLoS Biol."},{"issue":"17","key":"10.1016\/j.bcp.2018.07.005_b0200","doi-asserted-by":"crossref","first-page":"4817","DOI":"10.1016\/j.bmc.2017.07.028","article-title":"Design, synthesis, and pharmacological evaluation of a novel series of hormone sensitive lipase inhibitor","volume":"25","author":"Ogiyama","year":"2017","journal-title":"Bioorg. Med. Chem."},{"issue":"7","key":"10.1016\/j.bcp.2018.07.005_b0205","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1016\/j.bmc.2017.02.045","article-title":"Identification of a novel hormone sensitive lipase inhibitor with a reduced potential of reactive metabolites formation","volume":"25","author":"Ogiyama","year":"2017","journal-title":"Bioorg. Med. Chem."},{"issue":"16","key":"10.1016\/j.bcp.2018.07.005_b0210","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1016\/j.bmc.2016.06.022","article-title":"Identification of a novel boronic acid as a potent, selective, and orally active hormone sensitive lipase inhibitor","volume":"24","author":"Ogiyama","year":"2016","journal-title":"Bioorg. Med. Chem."},{"issue":"6","key":"10.1016\/j.bcp.2018.07.005_b0215","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1016\/j.bmc.2004.12.042","article-title":"Structure-activity relationship for aryl and heteroaryl boronic acid inhibitors of hormone-sensitive lipase","volume":"13","author":"Ebdrup","year":"2005","journal-title":"Bioorg. Med. Chem."},{"issue":"6","key":"10.1016\/j.bcp.2018.07.005_b0220","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1523\/JNEUROSCI.5693-09.2010","article-title":"Loss of retrograde endocannabinoid signaling and reduced adult neurogenesis in diacylglycerol lipase knock-out mice","volume":"30","author":"Gao","year":"2010","journal-title":"J. Neurosci"},{"issue":"12","key":"10.1016\/j.bcp.2018.07.005_b0225","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1038\/nchembio.1105","article-title":"DAGLbeta inhibition perturbs a lipid network involved in macrophage inflammatory responses","volume":"8","author":"Hsu","year":"2012","journal-title":"Nat. Chem. Biol."},{"issue":"Pt B","key":"10.1016\/j.bcp.2018.07.005_b0230","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.cbi.2016.04.004","article-title":"Lipases and their inhibitors in health and disease","volume":"259","author":"Nomura","year":"2016","journal-title":"Chem. Biol. Interact."},{"issue":"43","key":"10.1016\/j.bcp.2018.07.005_b0235","doi-asserted-by":"crossref","first-page":"27218","DOI":"10.1074\/jbc.272.43.27218","article-title":"cDNA cloning, tissue distribution, and identification of the catalytic triad of monoglyceride lipase. Evolutionary relationship to esterases, lysophospholipases, and haloperoxidases","volume":"272","author":"Karlsson","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"16","key":"10.1016\/j.bcp.2018.07.005_b0240","doi-asserted-by":"crossref","first-page":"10819","DOI":"10.1073\/pnas.152334899","article-title":"Brain monoglyceride lipase participating in endocannabinoid inactivation","volume":"99","author":"Dinh","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"6057","key":"10.1016\/j.bcp.2018.07.005_b0245","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1126\/science.1209200","article-title":"Endocannabinoid hydrolysis generates brain prostaglandins that promote neuroinflammation","volume":"334","author":"Nomura","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.bcp.2018.07.005_b0250","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.pharmthera.2017.02.033","article-title":"Monoglyceride lipase as a drug target: at the crossroads of arachidonic acid metabolism and endocannabinoid signaling","volume":"175","author":"Grabner","year":"2017","journal-title":"Pharmacol. Ther."},{"issue":"12","key":"10.1016\/j.bcp.2018.07.005_b0255","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1080\/13543776.2018.1389899","article-title":"A patent review of Monoacylglycerol Lipase (MAGL) inhibitors (2013\u20132017)","volume":"27","author":"Granchi","year":"2017","journal-title":"Expert. Opin. Ther. Pat."},{"issue":"1","key":"10.1016\/j.bcp.2018.07.005_b0260","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nchembio.129","article-title":"Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects","volume":"5","author":"Long","year":"2009","journal-title":"Nat. Chem. Biol."},{"issue":"9","key":"10.1016\/j.bcp.2018.07.005_b0265","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1021\/cn400116z","article-title":"Evaluation of NHS carbamates as a potent and selective class of endocannabinoid hydrolase inhibitors","volume":"4","author":"Niphakis","year":"2013","journal-title":"ACS Chem. Neurosci."},{"issue":"9","key":"10.1016\/j.bcp.2018.07.005_b0270","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/nn.2616","article-title":"Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system","volume":"13","author":"Schlosburg","year":"2010","journal-title":"Nat. Neurosci."},{"issue":"9","key":"10.1016\/j.bcp.2018.07.005_b0275","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1172\/JCI34827","article-title":"Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice","volume":"118","author":"Osei-Hyiaman","year":"2008","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.bcp.2018.07.005_b0280","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2174\/157489008786264014","article-title":"Rimonabant for the treatment of obesity","volume":"3","author":"Samat","year":"2008","journal-title":"Recent Pat. Cardiovasc. Drug Discov."},{"issue":"9468","key":"10.1016\/j.bcp.2018.07.005_b0285","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0140-6736(05)66374-X","article-title":"Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study","volume":"365","author":"Van Gaal","year":"2005","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.bcp.2018.07.005_b0290","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.biopsych.2011.04.022","article-title":"Differential role of anandamide and 2-arachidonoylglycerol in memory and anxiety-like responses","volume":"70","author":"Busquets-Garcia","year":"2011","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.bcp.2018.07.005_b0295","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1080\/14756366.2017.1375484","article-title":"Development of terphenyl-2-methyloxazol-5(4H)-one derivatives as selective reversible MAGL inhibitors","volume":"32","author":"Granchi","year":"2017","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"47","key":"10.1016\/j.bcp.2018.07.005_b0300","doi-asserted-by":"crossref","first-page":"48968","DOI":"10.1074\/jbc.M407841200","article-title":"Identification, cloning, expression, and purification of three novel human calcium-independent phospholipase A2 family members possessing triacylglycerol lipase and acylglycerol transacylase activities","volume":"279","author":"Jenkins","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"17","key":"10.1016\/j.bcp.2018.07.005_b0305","doi-asserted-by":"crossref","first-page":"7892","DOI":"10.1073\/pnas.1003585107","article-title":"A feed-forward loop amplifies nutritional regulation of PNPLA3","volume":"107","author":"Huang","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"2","key":"10.1016\/j.bcp.2018.07.005_b0310","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1194\/jlr.M011205","article-title":"Pnpla3\/adiponutrin deficiency in mice does not contribute to fatty liver disease or metabolic syndrome","volume":"52","author":"Basantani","year":"2011","journal-title":"J. Lipid Res."},{"issue":"3","key":"10.1016\/j.bcp.2018.07.005_b0315","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/oby.2007.563","article-title":"Regulation of adiponutrin expression by feeding conditions in rats is altered in the obese state","volume":"15","author":"Caimari","year":"2007","journal-title":"Obesity (Silver Spring)"},{"issue":"9","key":"10.1016\/j.bcp.2018.07.005_b0320","doi-asserted-by":"crossref","first-page":"6706","DOI":"10.1074\/jbc.M109.064501","article-title":"A sequence variation (I148M) in PNPLA3 associated with nonalcoholic fatty liver disease disrupts triglyceride hydrolysis","volume":"285","author":"He","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.bcp.2018.07.005_b0325","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/ng.257","article-title":"Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease","volume":"40","author":"Romeo","year":"2008","journal-title":"Nat. Genet."},{"issue":"3","key":"10.1016\/j.bcp.2018.07.005_b0330","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1002\/hep.23812","article-title":"Patatin-like phospholipase domain-containing 3\/adiponutrin deficiency in mice is not associated with fatty liver disease","volume":"52","author":"Chen","year":"2010","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.bcp.2018.07.005_b0335","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/hep.27242","article-title":"Pnpla3I148M knockin mice accumulate PNPLA3 on lipid droplets and develop hepatic steatosis","volume":"61","author":"Smagris","year":"2015","journal-title":"Hepatology"},{"issue":"23","key":"10.1016\/j.bcp.2018.07.005_b0340","first-page":"5212","article-title":"PNPLA3 overexpression results in reduction of proteins predisposing to fibrosis","volume":"25","author":"Pingitore","year":"2016","journal-title":"Hum. Mol. Genet."},{"issue":"6","key":"10.1016\/j.bcp.2018.07.005_b0345","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1002\/hep.25961","article-title":"Deficiency of carboxylesterase 1\/esterase-x results in obesity, hepatic steatosis, and hyperlipidemia","volume":"56","author":"Quiroga","year":"2012","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.bcp.2018.07.005_b0350","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1002\/hep.25881","article-title":"Liver specific inactivation of carboxylesterase 3\/triacylglycerol hydrolase decreases blood lipids without causing severe steatosis in mice","volume":"56","author":"Lian","year":"2012","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.bcp.2018.07.005_b0355","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.cmet.2010.02.005","article-title":"Loss of TGH\/Ces3 in mice decreases blood lipids, improves glucose tolerance, and increases energy expenditure","volume":"11","author":"Wei","year":"2010","journal-title":"Cell Metab."},{"issue":"6","key":"10.1016\/j.bcp.2018.07.005_b0360","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1002\/hep.28472","article-title":"Carboxylesterase 2 prevents liver steatosis by modulating lipolysis, endoplasmic reticulum stress, and lipogenesis and is regulated by hepatocyte nuclear factor 4 alpha in mice","volume":"63","author":"Li","year":"2016","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.bcp.2018.07.005_b0365","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1096\/fj.02-0728fje","article-title":"Inhibitors of hepatic microsomal triacylglycerol hydrolase decrease very low density lipoprotein secretion","volume":"17","author":"Gilham","year":"2003","journal-title":"FASEB J."},{"issue":"3","key":"10.1016\/j.bcp.2018.07.005_b0370","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.celrep.2016.12.070","article-title":"Human Carboxylesterase 2 Reverses Obesity-Induced Diacylglycerol Accumulation and Glucose Intolerance","volume":"18","author":"Ruby","year":"2017","journal-title":"Cell Rep."},{"issue":"7","key":"10.1016\/j.bcp.2018.07.005_b0375","first-page":"688","article-title":"Genetic variation in human carboxylesterase CES1 confers resistance to hepatic steatosis","volume":"1863","author":"Lian","year":"2018","journal-title":"BBA"},{"issue":"2","key":"10.1016\/j.bcp.2018.07.005_b0380","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/s13238-017-0437-z","article-title":"Carboxylesterases in lipid metabolism: from mouse to human","volume":"9","author":"Lian","year":"2018","journal-title":"Protein Cell"},{"issue":"2","key":"10.1016\/j.bcp.2018.07.005_b0385","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/phar.1194","article-title":"The role of human carboxylesterases in drug metabolism: have we overlooked their importance?","volume":"33","author":"Laizure","year":"2013","journal-title":"Pharmacotherapy"},{"issue":"5","key":"10.1016\/j.bcp.2018.07.005_b0390","doi-asserted-by":"crossref","first-page":"466","DOI":"10.2133\/dmpk.DMPK-12-RV-042","article-title":"The emerging role of human esterases","volume":"27","author":"Fukami","year":"2012","journal-title":"Drug Metab. Pharmacokinet."},{"issue":"Pt B","key":"10.1016\/j.bcp.2018.07.005_b0395","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.cbi.2016.02.011","article-title":"Carboxylesterases: General detoxifying enzymes","volume":"259","author":"Hatfield","year":"2016","journal-title":"Chem. Biol. Interact."},{"issue":"1","key":"10.1016\/j.bcp.2018.07.005_b0400","first-page":"37","article-title":"Mobilisation of triacylglycerol stores","volume":"1483","author":"Gibbons","year":"2000","journal-title":"BBA"},{"key":"10.1016\/j.bcp.2018.07.005_b0405","doi-asserted-by":"crossref","first-page":"25747","DOI":"10.1038\/srep25747","article-title":"Ces3\/TGH deficiency attenuates steatohepatitis","volume":"6","author":"Lian","year":"2016","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.bcp.2018.07.005_b0410","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1021\/bi962186d","article-title":"Purification and characterization of a porcine liver microsomal triacylglycerol hydrolase","volume":"36","author":"Lehner","year":"1997","journal-title":"Biochemistry"},{"issue":"11","key":"10.1016\/j.bcp.2018.07.005_b0415","doi-asserted-by":"crossref","first-page":"8027","DOI":"10.1074\/jbc.M605789200","article-title":"Attenuation of adipocyte triacylglycerol hydrolase activity decreases basal fatty acid efflux","volume":"282","author":"Wei","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2018.07.005_b0420","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ejmech.2018.02.052","article-title":"Facile synthesis of 1,2-dione-containing abietane analogues for the generation of human carboxylesterase inhibitors","volume":"149","author":"Binder","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"4","key":"10.1016\/j.bcp.2018.07.005_b0425","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1021\/acs.jmedchem.6b01849","article-title":"Selective inhibitors of human liver carboxylesterase based on a beta-lapachone scaffold: novel reagents for reaction profiling","volume":"60","author":"Hatfield","year":"2017","journal-title":"J. Med. Chem."},{"issue":"8","key":"10.1016\/j.bcp.2018.07.005_b0430","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1517\/13543776.2011.586339","article-title":"Carboxylesterase inhibitors","volume":"21","author":"Hatfield","year":"2011","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.bcp.2018.07.005_b0435","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.fitote.2017.01.010","article-title":"Recent progress in the discovery of natural inhibitors against human carboxylesterases","volume":"117","author":"Wang","year":"2017","journal-title":"Fitoterapia"},{"issue":"1","key":"10.1016\/j.bcp.2018.07.005_b0440","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.bbalip.2009.09.002","article-title":"Inhibition of carboxylesterase activity of THP1 monocytes\/macrophages and recombinant human carboxylesterase 1 by oxysterols and fatty acids","volume":"1801","author":"Crow","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"issue":"3","key":"10.1016\/j.bcp.2018.07.005_b0445","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1042\/BCJ20180008","article-title":"Silencing carboxylesterase 1 in human THP-1 macrophages perturbs genes regulated by PPARgamma\/RXR and RAR\/RXR: down-regulation of CYP27A1-LXRalpha signaling","volume":"475","author":"Mangum","year":"2018","journal-title":"Biochem. J."},{"issue":"7","key":"10.1016\/j.bcp.2018.07.005_b0450","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1124\/dmd.114.056994","article-title":"Screening of specific inhibitors for human carboxylesterases or arylacetamide deacetylase","volume":"42","author":"Shimizu","year":"2014","journal-title":"Drug Metab. Dispos."},{"issue":"2","key":"10.1016\/j.bcp.2018.07.005_b0455","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/nchembio.1429","article-title":"Integrated phenotypic and activity-based profiling links Ces3 to obesity and diabetes","volume":"10","author":"Dominguez","year":"2014","journal-title":"Nat. Chem. Biol."},{"issue":"12","key":"10.1016\/j.bcp.2018.07.005_b0460","first-page":"1133","article-title":"Es-x\/Ces1 prevents triacylglycerol accumulation in McArdle-RH7777 hepatocytes","volume":"1791","author":"Ko","year":"2009","journal-title":"BBA"},{"issue":"34","key":"10.1016\/j.bcp.2018.07.005_b0465","doi-asserted-by":"crossref","first-page":"21650","DOI":"10.1016\/S0021-9258(17)31855-0","article-title":"Human liver arylacetamide deacetylase. Molecular cloning of a novel esterase involved in the metabolic activation of arylamine carcinogens with high sequence similarity to hormone-sensitive lipase","volume":"269","author":"Probst","year":"1994","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.bcp.2018.07.005_b0470","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1194\/jlr.M000596","article-title":"Arylacetamide deacetylase attenuates fatty-acid-induced triacylglycerol accumulation in rat hepatoma cells","volume":"51","author":"Lo","year":"2010","journal-title":"J. Lipid Res."},{"issue":"24","key":"10.1016\/j.bcp.2018.07.005_b0475","doi-asserted-by":"crossref","first-page":"5109","DOI":"10.1038\/sj.emboj.7601924","article-title":"An acetylation\/deacetylation cycle controls the export of sterols and steroids from S. cerevisiae","volume":"26","author":"Tiwari","year":"2007","journal-title":"EMBO J."},{"issue":"11","key":"10.1016\/j.bcp.2018.07.005_b0480","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nrm.2017.76","article-title":"Cytosolic lipolysis and lipophagy: two sides of the same coin","volume":"18","author":"Zechner","year":"2017","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"6","key":"10.1016\/j.bcp.2018.07.005_b0485","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1124\/dmd.111.043877","article-title":"Transcription factor-mediated regulation of carboxylesterase enzymes in livers of mice","volume":"40","author":"Zhang","year":"2012","journal-title":"Drug Metab. Dispos."},{"issue":"7242","key":"10.1016\/j.bcp.2018.07.005_b0490","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/nature07976","article-title":"Autophagy regulates lipid metabolism","volume":"458","author":"Singh","year":"2009","journal-title":"Nature"},{"issue":"10 (Pt B)","key":"10.1016\/j.bcp.2018.07.005_b0495","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.bbalip.2017.06.008","article-title":"Breaking fat: the regulation and mechanisms of lipophagy","volume":"1862","author":"Schulze","year":"2017","journal-title":"Biochim. Biophys. Acta"},{"issue":"5","key":"10.1016\/j.bcp.2018.07.005_b0500","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/hep4.1056","article-title":"Hepatic lipophagy: new insights into autophagic catabolism of lipid droplets in the liver","volume":"1","author":"Schulze","year":"2017","journal-title":"Hepatol. Commun."},{"issue":"1","key":"10.1016\/j.bcp.2018.07.005_b0505","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/cdd.2012.63","article-title":"Regulation of lipid stores and metabolism by lipophagy","volume":"20","author":"Liu","year":"2013","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bcp.2018.07.005_b0510","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/282041","article-title":"Lipophagy: connecting autophagy and lipid metabolism","volume":"2012","author":"Singh","year":"2012","journal-title":"Int. J. Cell Biol."},{"issue":"10","key":"10.1016\/j.bcp.2018.07.005_b0515","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/ncb3407","article-title":"Protein kinase C controls lysosome biogenesis independently of mTORC1","volume":"18","author":"Li","year":"2016","journal-title":"Nat. Cell Biol."},{"issue":"14","key":"10.1016\/j.bcp.2018.07.005_b0520","doi-asserted-by":"crossref","first-page":"5281","DOI":"10.1021\/jm100499s","article-title":"Thiadiazole carbamates: potent inhibitors of lysosomal acid lipase and potential Niemann-Pick type C disease therapeutics","volume":"53","author":"Rosenbaum","year":"2010","journal-title":"J. Med. Chem."},{"issue":"25","key":"10.1016\/j.bcp.2018.07.005_b0525","doi-asserted-by":"crossref","first-page":"40037","DOI":"10.18632\/oncotarget.16673","article-title":"Lysosomal lipid hydrolysis provides substrates for lipid mediator synthesis in murine macrophages","volume":"8","author":"Schlager","year":"2017","journal-title":"Oncotarget"},{"issue":"Pt 1","key":"10.1016\/j.bcp.2018.07.005_b0530","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1042\/bj3370133","article-title":"Secretion and apparent activation of human hepatic lipase requires proper oligosaccharide processing in the endoplasmic reticulum","volume":"337","author":"Verhoeven","year":"1999","journal-title":"Biochem. J."},{"issue":"6","key":"10.1016\/j.bcp.2018.07.005_b0535","first-page":"1113","article-title":"Endoplasmic reticulum-localized hepatic lipase decreases triacylglycerol storage and VLDL secretion","volume":"1831","author":"Erickson","year":"2013","journal-title":"BBA"},{"issue":"7","key":"10.1016\/j.bcp.2018.07.005_b0540","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0022-2275(20)42629-X","article-title":"Development, food intake, and ethinylestradiol influence hepatic triglyceride lipase and LDL-receptor mRNA levels in rats","volume":"31","author":"Staels","year":"1990","journal-title":"J. Lipid Res."},{"issue":"2","key":"10.1016\/j.bcp.2018.07.005_b0545","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2165\/00003088-199834020-00003","article-title":"Clinical pharmacokinetics of fibric acid derivatives (fibrates)","volume":"34","author":"Miller","year":"1998","journal-title":"Clin. Pharmacokinet."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295218302739?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295218302739?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,27]],"date-time":"2022-08-27T05:37:02Z","timestamp":1661578622000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295218302739"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":109,"alternative-id":["S0006295218302739"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2018.07.005","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological intervention of liver triacylglycerol lipolysis: The good, the bad and the ugly","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2018.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}